Aug 6 (Reuters) - Suda Ltd :
* Suda receives positive response from FDA regarding sud-001
* Says has received a written response from the US FDA regarding the development plan for the company's sud-001 sumatriptan oral spray
* Source text for Eikon ID:nASX6GRl0C